Compare IDEXX Laboratories, Inc. (IDXX) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Vipshop Holdings Ltd - ADR — how do they compare? IDEXX Laboratories, Inc. trades at $572.11 (market cap $46.22B), while Vipshop Holdings Ltd - ADR trades at $14.66 (market cap $7.20B). The key difference: IDEXX Laboratories, Inc. is far larger — about 6.4× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays a 4.14% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | VIPS | |
|---|---|---|
Market Cap | $46.22B | $7.20B |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $20.68 |
52-Week Low | $526.44 | $12.92 |
Enterprise Value | $47.12B | $3.76B |
Dividend Yield | — | 4.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $595.76, up 1.55% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $4.27 versus $3.94 expected, driven by 9% organic revenue growth. The company raised full-year EPS guidance to $14.69–14.94, reflecting robust demand in companion animal diagnostics. Valuation ratios remain elevated with a P/E of 41.23, supported by high profitability margins including a net income margin of 25.03% and ROE of 74.21%.
Outlook is positive given consistent earnings beats, international expansion, and product innovation, but risks include premium valuation sensitivity and competitive pressures. The consensus price target of $683.33 implies 14.7% upside, with 57% of analysts rating it Buy. Investors should weigh growth durability against high multiples.
Vipshop (VIPS) trades at $15.41, down 1.72% on the day, with a bullish technical signal from moving averages. The stock shows attractive valuation metrics, including a P/E of 6.79 and P/S of 0.48, while maintaining solid profitability with a net income margin of 7.07%. Recent Q1 2026 earnings met expectations, and the company is pursuing growth through an outlet store REIT strategy, as reported by Seeking Alpha on May 22, 2026.
The outlook is cautiously positive, supported by low valuations and analyst consensus, but risks include revenue stagnation and macroeconomic pressures in China. Near-term catalysts depend on Q2 2026 earnings beating the $0.62 EPS estimate to reaffirm growth trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →
